Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Author(s) -
Matthew J. Ellis,
Vera J. Suman,
Jeremy Hoog,
Rodrigo Gonçalves,
Souzan Sanati,
Chad J. Creighton,
Katherine DeSchryver,
Erika C. Crouch,
Amy Brink,
Mark Watson,
Jingqin Luo,
Tao Yu,
Michael Barnes,
Mitch Dowsett,
G. Thomas Budd,
Eric P. Winer,
Paula Silverman,
Laura J. Esserman,
Lisa A. Carey,
Cynthia X. Ma,
Gary Unzeitig,
Timothy Pluard,
Pat W. Whitworth,
Gildy V. Babiera,
Julia Guenther,
Zoneddy Dayao,
David M. Ota,
Marilyn Leitch,
John A. Olson,
D. Craig Allred,
Kelly K. Hunt
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/4pwv-v868
Subject(s) - medicine , breast cancer , oncology , aromatase inhibitor , chemotherapy , aromatase , randomized controlled trial , cancer , gynecology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom